Beta
Rivastigmine
medication Under reviewAn acetylcholinesterase inhibitor used to treat dementia associated with Alzheimer's disease and Parkinson's disease.
Research summary
Scientific evidence for rivastigmine primarily comes from studies in patients with neurodegenerative conditions like Alzheimer's disease, where it demonstrates modest improvements in cognition, daily functioning, and global clinical impressions compared to placebo. No studies were identified that investigated rivastigmine in healthy human subjects, limiting conclusions about its effects or safety in this population.
No side effects tracked yet
No side effects have been reported by studies or users for this habit yet.
Research
No studies found yet. Request research to discover relevant studies.
Community updates
No updates yet for this supplement.
Be the first to share your experience!